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Objective:  To determine possible exposure-associated delays in auditory brainstem evoked 
potential (BAEP) latencies as an objective measure of neurobehavioral toxicity in 14-year-old 
children with developmental exposure to MeHg from seafood.  
Study design:   Prospective study of a birth cohort in the Faroe Islands, where 878 of eligible 
children (87%) were examined at age 14 years.  Latencies of BAEP peaks I, III, and V at 20 and 
40 Hz constituted the outcome variables.  Mercury concentrations were determined in cord 
blood and maternal hair, and in the child’s hair at ages 7 and 14. 
Results:   Latencies of peaks III and V increased by about 0.012 ms when the cord-blood 
mercury concentration doubled.  As seen at age 7, this effect appeared mainly within the I-III 
interpeak interval.  Despite lower postnatal exposures, the child’s hair-mercury level at age 14 
years was associated with prolonged III-V interpeak latencies.  All benchmark dose results were 
similar to those obtained for dose-response relationships at age 7 years.  
Conclusions:   The persistence of prolonged I-III interpeak intervals indicates that some 
neurotoxic effects from intrauterine MeHg exposure are irreversible.  A change in vulnerability 
to MeHg toxicity is suggested by the apparent sensitivity of the peak III-V component to recent 
MeHg exposure.  
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BAEP Brainstem auditory evoked potential 
BMD Benchmark dose 
BMDL Benchmark dose level 
BMR Benchmark response 
CV Coefficient of variation 
EP Evoked potential 
MeHg Methylmercury 
NRC National Research Council 
PCB Polychlorinated biphenyl
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Methylmercury (MeHg) is a worldwide contaminant of seafood and freshwater fish.1  MeHg 
toxicity can produce widespread adverse effects within the nervous system, especially when 
exposures occur during brain development.2-3  Early adverse effects have been characterized by 
administering neurobehavioral tests to children exposed in utero from maternal seafood diets.4-6  
Thus, a National Research Council (NRC) committee7 recently concluded that intrauterine MeHg 
exposure was the most critical and emphasized the findings from a prospective birth cohort study 
carried out in the Faroe Islands.5  The damage to the developing nervous system is thought to be 
potentially irreversible.7  The possibility also exists that exposure during postnatal development 
may induce brain lesions; clinical2,8 and experimental9 information suggests that such effects 
would tend to be more focal and particularly involve the sensory cortex and the granular layer of 
the cerebellum.  
 Current advisories on fish consumption issued by national and state authorities differ 
and mainly aim at pregnant women or women of reproductive age groups.1  Because the risk to 
children from dietary MeHg exposure is unclear, some fish advisories in the US also address 
‘young children’,10 or children up to, e.g., 8 years11 or 15 years.12  
 As an indicator of MeHg neurotoxicity, delayed evoked potential (EP) latencies have 
been recorded in poisoning victims13,14 and in laboratory animals.15  In contrast to 
neuropsychological test outcomes, this measure is thought to be independent of socioeconomic 
covariates.16  As illustrated by environmental exposure to lead, EP abnormalities constituted 
important objective evidence on neurotoxic effects in children.17  
 In an extended follow-up of the Faroese birth cohort, we have assessed brainstem 
auditory evoked potentials (BAEPs) at age 14 years.  We previously showed that increased 
intrauterine MeHg exposures were associated with delayed peak III latencies at age 7 years.5,18  
We hypothesized that these delays would remain at age 14 and that BAEP latencies would also 
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be sensitive to MeHg from adolescent seafood diets.  
 
METHODS  
Study Population and Follow-up 
A cohort of 1,022 births was assembled in the Faroe Islands during a 21-month 
period of 1986-1987.19,20  The primary indicator of intrauterine exposure to MeHg was the 
mercury concentration in cord blood, and concentrations in maternal hair at parturition were also 
determined.19  MeHg exposures varied considerably: 15% of the mothers had hair mercury 
concentrations above 10 g/g, while 4% were below 1 g/g, a level that corresponds to the 
exposure limit recommended by the NRC committee.7  Concomitant exposure to 
polychlorinated biphenyls (PCBs) was determined from the concentration in umbilical cords from 
438 cohort members.5  The first follow-up examination was carried out seven years later and 
included hair-mercury assessment, evoked potentials and pediatric examination.5,21   
At age 14 years, a total of 878 of 1,010 live cohort members (86.9%) were examined.  
Most examinations took place at the National Hospital in Tórshavn, the capital of the Faroe 
Islands, during April-June of 2000 and 2001.  For families who had moved, examinations were 
also offered in Odense, Denmark in November 2000.  Each day, four children were examined 
during the morning, and four during the afternoon.  The examinations were conducted by a team 
of health professionals who had no access to information on individual exposure levels.  The 
438 boys and 440 girls examined had an average age of 13.83 (SD, 0.32) years.  
Hair samples were again obtained, and the proximal 2-cm segment was analyzed by 
flow-injection cold-vapor atomic absorption spectrometry after digestion of the hair sample in a 
microwave oven.5  The total analytical imprecision for this analysis was estimated to be 4.3% 
and 5.5% at mercury concentrations of 4.7 g/g and 11.1 g/g, respectively.  Accuracy was 
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ensured by participation in the Canadian Hair Mercury Quality Control Program; all our results 
were within one SD of the adjusted mean.  The high analytical quality is comparable to previous 
performance.5,19  Results in g may be converted to nmol by multiplying by 5.0.  
The study protocol was approved by the ethical review committee for the Faroe 
Islands and the institutional review board at the U.S. institution, and parental informed consent 
was obtained.  
 
Neurological examination  
A thorough pediatric examination included otoscopy and assessment of neurological optimality.  
None of the children had current middle ear infection.  A total of 18 children examined had 
neurological disorders thought to be independent of MeHg exposure and were therefore excluded 
from the data analysis: Congenital hypothyreosis, 1; Gilles de la Tourette’s syndrome, 1; dystonia, 
3; epilepsia, 2; polyneuropathy sequelae, 1; mental retardation, 1; psychomotor retardation, 4; 
meningitis sequelae, 1; concussion, 3; and deafness, 1. None of the subjects examined had 
diabetes. The MeHg exposure of these subjects did not differ from that of other cohort members. 
 BAEPs were determined in all participating subjects, except for one refusal (N = 859).  
We used a four-channel electromyograph (Medelec Sapphire-4ME) also employed previously.5,21  
Click signals at an intensity of 65 dB HL (0.1 ms impulses of alternating polarity) were presented 
to the right ear through shielded ear phones at 20 Hz and 40 Hz (sampling time, 0.01 ms); the 
other ear was masked with white noise at an intensity of 45 dB HL.  A frequency of 50 Hz was 
also attempted, but peak I was poorly defined at this click rate.  EPs were recorded using three 
standard EEG electrodes placed on the vertex, the right mastoid ipsilateral to stimulation and the 
left mastoid (ground).  While 1,024 responses were used seven years before,5,21 the number was 
increased to 2,048 to improve the definition of peak I.  Amplification and filtration were 
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unchanged, and one replication of each condition was again carried out for calculation of average 
peak latencies.  The coefficients of variation (CVs) for duplicate assessments remained higher 
for peak I (mean, 8.4 %) than for peaks III and V (means, 4.3 % and 3.7 %, respectively).  As an 
additional part of the quality assurance, latencies from the first 250 children examined in 
Tórshavn in 2000 were scored twice by the same examiner (KM).  The results of this blinded 
scoring-rescoring showed average CVs of 8.9%, 4.4%, and 3.7% for peaks I, III, and V, i.e. 
similar to the duplicate assessments.  Thus, although highly appropriate for latency 
measurement, the study circumstances did not allow accurate assessment of peak amplitudes.  
Peaks I, III, and V are thought to reflect the volume-conducted electric activity from the acoustic 
nerve, pons (superior olivary nucleus), and midbrain (inferior colliculi), respectively.16  
 Audiometry was carried out by a trained nurse using Interacoustics Diagnostic 
Audiometer AD229 with a Peltor H7A headphone in a sound-insulated room.  The 
patient-controlled Hughson-Westlake procedure was used in accordance with ISO 8253-1.  A 
threshold was defined as two out of three correct responses in a procedure with 5 dB increases 
and 10 dB decreases.  Pure-tone air-conduction hearing thresholds were measured at 125, 250, 
500, 750, 1000,1500, 2000, 3000, 4000, 6000, and 8000 Hz.  Two children did not complete 
their audiometry examination.  
 
Data analysis 
Pearson’s correlation coefficients were used to assess bivariate relationships between exposure 
parameters.  Regression analysis was used to determine the association of MeHg exposure with 
the outcome variables.  Age and sex may be important predictors of BAEP latencies16,21 and 
were therefore included as independent variables along with the exposure parameters.  In 
addition, confounders previously included in the analysis of neuropsychological test results5 were 
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screened for possible associations with the outcomes in the present study, but no pattern was 
found.  Further models included as an independent variable the latency result obtained 7 years 
previously along with the age at that examination.  Additional analyses also incorporated PCB 
and postnatal MeHg exposure parameters as explanatory variables.  Because of skewed 
distributions, logarithmic transformation of the contaminant concentrations was used, and the 
mercury regression coefficients therefore correspond to the change in the dependent variable 
associated with a 10-fold increase in MeHg exposure.  Significant exposure effects were further 
explored in generalized additive models, which do not require linearity assumptions while 
providing a smooth nonparametric dose-response curve.22  
 Calculation of the benchmark dose (BMD) is increasingly used for comparison of 
dose-response curves at low dose levels and for determining exposure limits.7,18  The BMD is 
the dose of a substance that increases the risk of an abnormal response by a benchmark response 
(BMR), i.e., from P0 (usually 5%) for an unexposed child to P0 + BMR for a child exposed at the 
BMD.23 The NRC committee used a BMR of 5% so that an exposure at the corresponding BMD 
will double the risk of an abnormal response.7  To take the statistical uncertainty into account, a 
lower 95% confidence limit (BMDL) for the BMD is also determined.  Using linear 
dose-response models, BMDLs expressed as the maternal hair mercury concentration were about 
10 g/g for the most sensitive neuropsychological and BAEP outcomes in the Faroese children at 
age 7 years.7,18,24  For comparison with these dose-response associations, we used the same 
default settings when calculating BMDL results for BAEP outcomes at age 14 years.  
 
RESULTS  
Prolonged Peak III and Peak V Latencies at Higher Prenatal MeHg Exposures Were Due to 
Increased I-III Intervals That Were Prolonged Already 7 Years Before 
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Hair-mercury concentrations at age 14 years (Table I) indicated that the children’s current MeHg 
exposure had increased since the previous examination (p < 0.001).  Approximately half of the 
children now exceeded the hair-mercury limit of 1 g/g, but the average corresponded to only 
one-fourth of the concentrations in maternal hair at child birth.  Nonetheless, the different sets of 
exposure biomarkers correlated well.  
 The BAEP latencies were similar to the results obtained at age 7,5,18,21 and again 
differed as expected16 between boys and girls.  Age had no effect within the limited range 
studied.  
 Intrauterine MeHg exposure biomarkers showed several statistically significant 
associations with the BAEP latencies, especially peaks III and V at both frequencies (Table II).  
The same tendency was seen for the interpeak I-III latency, despite being affected by the greater 
imprecision of peak I determinations.  Because peak I and interpeak III-V latencies were clearly 
not associated with the intrauterine exposure level, MeHg appeared to affect mainly the I-III 
interval.  Neither sex nor age was associated with MeHg exposure levels, and confounder 
adjustment therefore did not affect the mercury regression coefficients.  
 Given the more robust findings for the full peak III latency (Figure 1), its better 
precision, and the parallel results for this outcome obtained at age 7 years,5,18 this outcome 
parameter was selected for more detailed calculations.  Inclusion of the postnatal exposure 
biomarkers as additional predictors did not affect the regression coefficients for the prenatal 
exposures.  However, they were almost completely abolished when peak III latencies at age 7 
were incorporated as predictors.  
Current MeHg Exposures Were Associated with Prolonged III-V Interpeak Latencies 
 The regression coefficients also suggested an effect of recent MeHg exposure, but 
only on the III-V interpeak interval (Table II, Fig 2).  This association was not affected by 
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inclusion of prenatal exposure biomarkers, and neither did the lower mercury concentrations at 
age 7 seem to affect this outcome parameter.  At the same time, this interpeak variable was 
significantly associated with all other peak latencies, except for the peak I latency.  
 Inclusion of PCB exposure within the subset of the cohort where this parameter was 
available did not affect any of the MeHg regression coefficients.  In addition, the PCB 
parameter did not reach statistical significance in any of the analyses.   
 Audiometry results generally showed normal hearing, and hearing thresholds above 
30 dB(A) were recorded for only about 2% of the children.  Hearing thresholds were not 
associated with MeHg exposure, except for 4 kHz on the right ear (Table III).  The association 
with the peak III latency (Table III) was due to a prolonged latency for peak I at increased 
hearing thresholds, while the interpeak I-III interval was unaffected.  PCB exposure and 
postnatal MeHg exposure were not associated with the audiometry results.  Inclusion of the 
hearing threshold at 4 kHz as a predictor of BAEP latencies changed the mercury regression 
coefficients only marginally.  
Benchmark Dose Results Were Similar to Those Seen at Age 7 Years 
 The relative magnitude of the regression coefficients (Table II) can be judged by 
comparison with the variability of the outcome parameters.  Thus, for peak III latencies, an 
average regression coefficient of about 0.04 corresponds to almost 25% of the SD.   Because a 
logarithmic transformation of the mercury concentrations was used, the effect of a doubling of 
the exposure can be determined by multiplying the regression coefficient by 0.301.  Accordingly, 
a doubling of the prenatal exposure results in a latency prolongation by about 7% of the SD.  
Similarly, a doubling of the current exposure level is associated with a prolongation of the 
interpeak III-V interval by about 5% of the SD.  
 Additional comparisons may be based on benchmark dose calculations. Prenatal 
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BMDL results for peak III at the two frequency conditions corresponded to an average of about 
10 g/g hair based on either cord blood or maternal hair.  For the III-V interval, postnatal 
BMDLs averaged about 5 g/g for the child’s hair-mercury concentration at age 14 years. 
 
DISCUSSION 
The developing brain is thought to constitute the most vulnerable organ in regard to MeHg 
exposure.1,7  Emphasis in risk assessment has therefore been placed on neurological functions of 
children with intrauterine exposure to this neurotoxicant, and previous studies have applied 
neuropsychological function as a key measure of adverse effects.4-6  In parallel, 
neurophysiological tests, such as BAEP assessment, have found use in population studies as 
highly standardized, rapid, painless, and inexpensive procedures.16,25  Prolonged BAEP latencies 
have been reported as an effect of exposure to MeHg 13-15 and other neurotoxicants, such as 
lead.17,25  
 In the present study, we report that BAEP latency assessments were highly 
reproducible and that several latencies at age 14 years showed a positive association with MeHg 
exposure.  Intrauterine exposure was mainly associated with delays in peaks III and V, and the 
I-III interpeak interval appeared to be most sensitive.  This result is in accordance with 
previously reported exposure-associated delays in the same cohort examined at age 7 years and in 
a cross-sectional study of 7-year-old children from another North Atlantic fishing population.18,21  
However, the regression coefficients at age 721 were about twice the magnitude observed seven 
years later. Furthermore, adjustment of the most recent peak latency for the result obtained 7 
years previously virtually abolished the mercury effect.  These observations suggest a lasting 
neurotoxic impact of the intrauterine exposure, although the reduced regression coefficient may 
perhaps indicate some degree of compensation.  The peak III results also suggest that this 
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outcome is not affected by postnatal exposures at the levels occurring in this population. 
 More recent MeHg exposure, as reflected by the current hair mercury concentrations 
of the children, was associated with a prolonged interpeak III-V interval.  This observation is 
noteworthy, because the children’s current exposures averaged less than one-fourth of the 
maternal levels during pregnancy, and a single hair analysis probably is a very inaccurate marker 
of the causative postnatal exposure levels.  Although paired mother-child exposure data 
correlated well and thereby suggested relatively stable dietary habits within each household, only 
the recent exposure level was associated with this outcome parameter.  Hair-mercury 
concentrations at age 7 years were the lowest and did not contribute to this association.  
 Despite the delayed BAEP latencies, the audiometry data suggested only limited, if 
any impact of MeHg exposure on hearing thresholds.  These results parallel those obtained at 
age 7 years.26  All BAEP latencies were recorded with a sound pressure adjusted for audiometry 
results; no association between hearing thresholds and BAEP latencies was detected, except for 
peak I at a single sound frequency on one side only.  Although deafness has been reported in 
severe congenital MeHg poisoning cases,2 hearing loss is not a uniform finding in less serious 
childhood poisonings or in adult cases.2,27  
 The MeHg-associated prolongation of BAEP latencies in the present study was subtle 
and comparable to effects associated with lead exposure.17,25  These changes are much less 
extensive than clinical findings in patient groups, such as the abnormal BAEP waves with poorly 
defined or absent peaks III and V in multiple sclerosis, and the markedly prolonged interpeak 
latencies in patients with acoustic neurinoma or diabetes mellitus.28  However, the relative 
change parallels the extent of neuropsychological deficits determined in the cohort children at age 
7 years.5  Thus, in several functional domains, a doubling of the intrauterine MeHg exposure 
showed a decrease in performance by 5-10% of the SD.5,29  Subtle neurotoxic effects, 
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sometimes expressed in terms of IQ points, have important societal implications in regard to 
educational achievement and earning potential.30  
 The BMDL represents a statistically defined point on the dose-response curve that 
allows comparison between low-range toxicity studies.  However, the BMDL should not be 
interpreted as a threshold indicator.  Indeed, significant exposure-related deficits on 
neuropsychological tests at age 7 years were documented at maternal hair-mercury concentrations 
below the BMDL.5  Previous calculations7,12,24,31 based on the most sensitive neurological, 
neuropsychological and neurophysiological endpoints all indicate a BMDL of about 10 g/g 
maternal hair, i.e., the same level as found for peak III delays at age 14 years.  We found that the 
postnatal BMDL for the prolonged III-V interpeak interval was about one-half of that.  However, 
due to statistical uncertainty, this difference may not necessarily reflect the relative toxic 
potentials of prenatal and postnatal exposures.  
 All observational studies have weaknesses, because all important determinants cannot 
be controlled a priori.  However, the present study involved a large birth cohort that has been 
followed prospectively for 14 years and characterized in substantial detail with regard to 
developmental MeHg exposure levels.  The participation rate at age 14 years was very high, 
thereby reducing the concern that the results may have been affected by differential follow-up 
rates.  An important strength of this study is that the examinations relied on the same 
methodology as 7 years before, and the same examiner, who was blinded in regard to exposure 
data and prior peak latency results.  The validity of the results was supported by extensive 
quality assurance data.  In addition, the outcome measures were confirmed to be independent of 
socioeconomic confounders.  The known16 BAEP peak latency difference between boys and 
girls was replicated, but sex was not associated with MeHg exposure and therefore did not cause 
confounding.  At age 7 years,21 prolongations of the peak I latency occurred as a result of 
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middle ear infection, but at age 14 years this trait was absent.   
 An important limitation is that only few postnatal exposure estimates were obtained 
and that the prenatal and postnatal exposure indicators were highly associated.  Although dietary 
patterns may have been rather stable, the postnatal exposure biomarkers do not necessarily 
represent the magnitude of the toxic exposure at susceptible time windows.  Any exposure 
misclassification would be mostly random and would tend to dilute the associations with the 
outcome variables, although this dilution would be limited by the wide exposure interval covered 
within this cohort.  Despite this bias, the size of the cohort allowed separation of latency 
prolongations associated with intrauterine and recent MeHg exposures.  The fact that peaks III 
and V at both frequencies showed clear associations with two independent indicators of prenatal 
MeHg exposure, and not with indicators of postnatal exposure, suggests that the findings are 
robust and credible for human health risk assessment.  Likewise, although unanticipated, the 
association of the prolonged interpeak III-V interval with recent MeHg exposure only was also 
seen at both frequencies.  
 As previously reported for the results at age 7 years,26 concomitant prenatal exposure 
to PCBs, which occur in whale blubber sometimes eaten in the Faroes, did not influence the 
BAEP outcomes.  Developmental exposure to PCBs is now thought to affect primarily cochlear 
function and impact on BAEP amplitudes rather than latencies.32  In addition, the lead exposures 
were comparatively low and not associated with mercury.19  The generalizability of this study 
would therefore not seem to be limited by concomitant exposures to other neurotoxicants.  
 Although a chance finding in multiple comparisons cannot be ruled out, the 
possibility that prenatal and postnatal MeHg exposure may affect different targets in the brain is 
supported by both experimental and clinical evidence.  Thus, prenatal exposure of rats to toxic 
amounts of MeHg results in severe lesions that include the brainstem, while effects of postnatal 
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treatment are less diffuse and particularly involve the sensory cortex.9  Similarly, 
neuropathological and imaging evidence reveals a greater degree of focal cortical damage with 
postnatal MeHg exposure as compared to congenital cases.2,3,8  The results of this study would 
therefore seem to be plausible, although the specific vulnerability of the interpeak III-V interval 
to postnatal MeHg exposure was not predicted.  While the significance of postnatal MeHg 
exposure needs to be further documented in independent studies with more frequent exposure 
assessments, our results suggest that developmental vulnerability to MeHg neurotoxicity is likely 
to extend into the teenage period. 
 In conclusion, these results on EPs support the notion that intrauterine exposure to 
MeHg from seafood may cause lasting adverse effects on the central nervous system.  They also 
indicate that recent MeHg exposure as assessed at age 14 years is associated with EP delays that 
differ from those incurred from exposure in utero.  The possibility that peak latencies may 
distinguish between effects incurred prenatally and postnatally deserves attention in future studies.  
The potential postnatal vulnerability of the brain would mean that children ought to be protected 
against MeHg exposure to the same extent as pregnant women. 
 
We are grateful to the cohort families for their loyal support, to the highly competent 
clinical staff in Tórshavn, and to Dr David A Otto for advice regarding the quality assurance for 
the BAEP measurements.  
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Table I.   Results of developmental methylmercury exposure biomarkers for 859 birth cohort 
members without neurological disease examined at age 14 years*  
 
 
Biomarker 
 
 
n 
 
  
Geometric 
average 
 
Interquartile 
range 
  
Association with 
cord blood† 
 
Cord blood (µg mercury/L) 
 
835 
  
22.6 
 
13.2-40.8 
  
(1) 
 
Hair (µg mercury/g) 
      
 
  Maternal, parturition 
 
855 
  
4.22 
 
2.55-7.68 
  
0.77 
 
  Child, 7 years 
 
800 
  
0.60 
 
0.34-1.24 
  
0.33 
 
  Child, 14 years 
 
 
839 
  
0.96 
 
0.45-2.29 
  
0.35 
 
*Concentrations in µg may be converted to nmol by multiplying by 5.0. 
†Correlation coefficient after logarithmic transformation.
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Table II.   Mean results and regression coefficients for logarithmic transformations of mercury 
exposure biomarkers as predictors of latencies of brainstem auditory evoked potentials (ms) in 
859 Faroese children at 14 years 
  
 
 
Regression coefficient* (P value) 
 
  
Mean (SD) 
 
Cord blood 
 
 
Maternal hair
 
 
Hair at 7 yrs 
  
Hair at 14 yrs 
  (n=835) (n=855) (n=800)  (n=839) 
 
20 Hz 
      
 
  I 
 
1.770 (0.129) 
 
0.015 (0.213) 
 
0.001 (0.942) 
 
-0.005 (0.622) 
  
0.006 (0.553) 
 
  III 
 
3.952 (0.161) 
 
0.045 (0.002) 
 
0.037 (0.014) 
 
0.012 (0.335) 
  
0.001 (0.907) 
 
  V 
 
5.788 (0.204) 
 
0.049 (0.006) 
 
0.032 (0.085) 
 
-0.002 (0.901) 
  
0.018 (0.159) 
 
  I-III 
 
2.183 (0.152) 
 
0.027 (0.051) 
 
0.036 (0.013) 
 
0.017 (0.150) 
  
-0.004 (0.631) 
 
  III-V 
 
1.835 (0.132) 
 
0.004 (0.722) 
 
-0.005 (0.686) 
 
-0.014 (0.181) 
  
0.017 (0.056) 
 
40 Hz 
      
 
  I 
 
1.806 (0.169) 
 
0.027 (0.089) 
 
0.014 (0.410) 
 
0.007 (0.602) 
  
0.012 (0.293) 
 
  III 
 
4.054 (0.178) 
 
0.032 (0.048) 
 
0.023 (0.169) 
 
0.008 (0.536) 
  
0.002 (0.847) 
 
  V 
 
5.954 (0.214) 
 
0.048 (0.009) 
 
0.036 (0.066) 
 
0.006 (0.686) 
  
0.024 (0.070) 
 
  I-III 
 
2.248 (0.190) 
 
0.004 (0.805) 
 
0.009 (0.614) 
 
0.001 (0.925) 
  
-0.010 (0.430) 
 
  III-V 
 
1,900 (0.148) 
 
0.015 (0.226) 
 
0.013 (0.383) 
 
-0.002 (0.852) 
  
0.022 (0.028) 
 
*Adjusted for sex and age; due to the logarithmic transformation of the mercury concentrations, 
the regression coefficient indicates the change in the dependent variable associated with an 
increase in MeHg exposure by a factor of 10. 
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Table III.   Cord-blood mercury concentration (geometric mean) and peak III latency of the 
brainstem auditory evoked potentials measured at age 14 years (arithmetic means) in 857 Faroese 
cohort children in relation to the hearing threshold at 4kHz on the right ear.  
 
Peak III latency (ms) 
 
 
Hearing 
threshold 
[dB(A)] 
 
  
 
n 
 
 
 
Mercury 
concentration** 
 
 
20Hz*** 
 
 
40 Hz*** 
 
 
<0 
  
158 
 
20.0 
 
3.94 
 
4.03 
 
0 
  
171 
 
20.8 
 
3.92 
 
4.02 
 
5 
  
218 
 
22.8 
 
3.94 
 
4.03 
 
10 
  
161 
 
24.9 
 
3.99 
 
4.09 
 
>10 
 
  
136 
 
25.4 
 
3.98 
 
4.10 
 
P value for association (Spearman’s correlation coefficient) with hearing threshold: 
** <0.01; *** < 0.001  
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Fig 1.   Prenatal dose-effect relationship between maternal hair mercury at birth and the peak III 
latency of the brainstem auditory evoked potentials in 859 Faroese children at 14 years adjusted 
for sex and age. The association is estimated in a generalized additive model analysis in which a 
smooth nonparametric curve (equivalent degrees of freedom, 3) is fitted to the data while 
adjusting for confounders.  The broken lines indicate the pointwise 95% confidence interval for 
the dose-response relationship.  Each vertical line above the horizontal axis represents one 
observation at the exposure level indicated.  To convert to nmol/g, multiply mercury 
concentration in µg/g by 5.0.
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Fig 2.   Postnatal dose-effect relationship between the child’s current hair mercury and the 
interpeak III-V latency of the brainstem auditory evoked potentials in 859 Faroese children at 14 
years adjusted for sex and age. The association is estimated in a generalized additive model 
analysis as in Figure 1, but the horizontal scales differ.  The broken lines indicate the pointwise 
95% confidence interval for the dose-response relationship.  Each vertical line above the 
horizontal axis represents one observation at the exposure level indicated.  To convert to nmol/g, 
multiply mercury concentration in µg/g by 5.0.   
